ICOS-Targeted Peptide Imaging Informs Therapeutic Response of STING Agonist in Lung Adenocarcinoma. Duan S, Tan B, Mao Y, Zhang Y, et al. J Nucl Med 2026;67:1062-1069.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Duan S, Tan B, Mao Y, Zhang Y, et al. ICOS-Targeted Peptide Imaging Informs Therapeutic Response of STING Agonist in Lung Adenocarcinoma. J Nucl Med 2026;67:1062-1069.
PMID: 41991338